AUTHORS
Richard D. Kelly
  • Richard D. Kelly
  • rkelly@oblon.com
  • (703) 412-6241
Marina I. Miller, Ph.D.
  • Marina I. Miller, Ph.D.
  • mmiller@oblon.com
  • (703) 412-6044
Daniel J. Pereira, Ph.D.
  • Daniel J. Pereira, Ph.D.
  • dpereira@oblon.com
  • (703) 413-6560
Yuki  Onoe
  • Yuki Onoe
  • yonoe@oblon.com
  • +81-3-6212-0550
Grace  Kim
  • Grace Kim
  • gkim@oblon.com
  • (703) 412-1425
Derek  Lightner, Ph.D.
  • Derek Lightner, Ph.D.
  • dlightner@oblon.com
  • (703) 236-2680
Elissa  Sanford
  • Elissa Sanford
  • esanford@oblon.com
  • (703) 413-6578

No matches found...

ACCOLADES
View Accolades
CATEGORIES
Pharma Alice Standard Federal Circuit USPTO PTAB Rules Cannabis Supreme Court Patent Eligibility 101 Mayo Myriad Gene Segments IPR Antibodies AI Artificial Intelligence Life Cycle Management
STAY UPDATED

Follow Us

    

 

Copyright © Oblon, McClelland, Maier & Neustadt, L.L.P. | Disclaimer

The opinions, commentary and characterizations provided to this online forum by the authors and moderators are provided for encouraging discussion, thought and debate on important design patent issues. These postings are in no way representative of the opinions of the Oblon firm, or its clients, but rather the personal views of the individual authors.



Hosted on the FirmWise platform.
Copyright © Oblon, McClelland, Maier & Neustadt, L.L.P. | Disclaimer

The opinions, commentary and characterizations provided to this online forum by the authors and moderators are provided for encouraging discussion, thought and debate on important design patent issues. These postings are in no way representative of the opinions of the Oblon firm, or its clients, but rather the personal views of the individual authors.



Hosted on the FirmWise platform.